Insights

Gathering insights about Lexico…

Similar companies to Lexico

Lexico Tech Stack

Lexico uses 8 technology products and services including LiveIntent, Swiper, jQuery, and more. Explore Lexico's tech stack below.

LiveIntent
Advertising
Swiper
Javascript Libraries
jQuery
Javascript Libraries
Elementor
Page Builders
Cloudflare Bot Management
Security
reCAPTCHA
Security
Bootstrap
UI Frameworks
ZURB Foundation
UI Frameworks

Media & News

GSA Capital Partners LLP Sells 1,627,753 Shares of Lexicon Pharmaceuticals, Inc. $LXRX
GSA Capital Partners LLP lessened its stake in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) by 57.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,202,906 shares of the biopharmaceutical company's stock after selling 1,627,753 shares during the quarter. GSA Capital
Feb 18, 2026 | www.defenseworld.net
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“ Lexicon ”) today announced the closing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001, and concurrent private placement of 22,400,000 shares of common stock and 367,145 shares of series b convertible preferred stock (the “ Series B Convertible Preferred Stock ”). The shares of common stock offered pursuant to the public offering were sold at a public offering price of $1.30 per share and the shares of preferred stock were sold at a price of $65 per share. The offerings closed on February 2, 2026.
Feb 06, 2026 | www.globenewswire.com
Invus Global Management, Llc Purchases 1,538,462 Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX - Get Free Report) Director Invus Global Management, Llc bought 1,538,462 shares of the firm's stock in a transaction that occurred on Monday, February 2nd. The shares were acquired at an average cost of $1.30 per share, for a total transaction of $2,000,000.60. Following the completion of the acquisition, the director
Feb 06, 2026 | www.defenseworld.net
Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
THE WOODLANDS, Texas, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“ Lexicon ”) today announced the pricing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001. The shares of common stock being offered pursuant to the public offering are being offered at a public offering price of $1.30 per share. All of the shares are being offered by Lexicon. The gross proceeds from the public offering are expected to be $41.6 million, before deducting underwriting discounts and commissions and other offering expenses. The public offering is expected to close on or about February 2, 2026, subject to the satisfaction of customary closing conditions. In addition, Lexicon has granted the underwriters a 30-day option to purchase up to an additional 4,800,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
Jan 30, 2026 | www.globenewswire.com
Lexicon Announces Proposed Public Offering of Common Stock
THE WOODLANDS, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“ Lexicon ”) today announced that it has commenced an underwritten public offering to offer and sell, subject to market and other conditions, shares of its common stock, par value $0.001. In addition, Lexicon intends to grant the underwriters a 30-day option to purchase additional shares of common stock. There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.
Jan 29, 2026 | www.globenewswire.com
Financial Contrast: NovAccess Global (OTCMKTS:XSNX) vs. Lexicon Pharmaceuticals (NASDAQ:LXRX)
NovAccess Global (OTCMKTS:XSNX - Get Free Report) and Lexicon Pharmaceuticals (NASDAQ: LXRX - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk. Analyst Ratings This is a summary of
Jan 26, 2026 | www.defenseworld.net
Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary
THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January 27, 2026.
Jan 23, 2026 | www.globenewswire.com

Lexico's Email Address Formats

Lexico uses at least 1 format(s):

Lexico Email Formats	Example	Percentage
First@lexicoconsulting.com	John@lexicoconsulting.com	50%
First@lexicoconsulting.com	John@lexicoconsulting.com	50%

Frequently Asked Questions

Where is Lexico's headquarters located?

Lexico's main headquarters is located at 507 South 2nd Street Milwaukee, Wisconsin 53204 United States. The company has employees across 1 continents, including North America.

What is Lexico's stock symbol?

Lexico is a publicly traded company; the company's stock symbol is LXRX.

What is Lexico's official website and social media links?

Lexico's official website is lexicoconsulting.com and has social profiles on LinkedIn.

What is Lexico's NAICS code?

Lexico's NAICS code is 5416 - Management, Scientific, and Technical Consulting Services.

How many employees does Lexico have currently?

As of February 2026, Lexico has approximately 31 employees across 1 continents, including North America. Key team members include Vp Of Growth Development: J. E.Head Of Hr & Talent: R. M.Founder, Cxo: C. S.. Explore Lexico's employee directory with LeadIQ.

What industry does Lexico belong to?

Lexico operates in the Business Consulting and Services industry.

What technology does Lexico use?

Lexico's tech stack includes LiveIntentSwiperjQueryElementorCloudflare Bot ManagementreCAPTCHABootstrapZURB Foundation.

What is Lexico's email format?

Lexico's email format typically follows the pattern of First@lexicoconsulting.com. Find more Lexico email formats with LeadIQ.

When was Lexico founded?

Lexico was founded in 2016.

Lexico

Q: What is Lexico's official website and social media links?

Lexico's official website is lexicoconsulting.com. Lexico has social profiles on LinkedIn.

Q: How many employees does Lexico have currently?

Lexico has approximately 31 employees.

Q: What technology does Lexico use?

Lexico's tech stack includes Apache, Apache HTTP Server, Font Awesome, RSS, Cloudflare.

Business Consulting and ServicesWisconsin, United States11-50 Employees

Lexico is a full-service transformation services company. We partner with executives to lead "readiness to results" solutions for challenges or opportunities that require transformation at their core. Our 360º business view solutions–incorporating technology, talent, culture and change–drive project assurance, amplifies capabilities and delivers sustainable outcomes for our clients.

Company Overview

Headquarters: 507 South 2nd Street Milwaukee, Wisconsin 53204 United States
Website: lexicoconsulting.com
Stock Symbol: LXRX
NAICS Code: 5416 - Management, Scientific, and Technical Consulting Services
Founded: 2016
Employees: 11-50

Media & News

Funding & Financials

$25M$50M
Lexico's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$25M$50M
Lexico's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Lexico

ProWritingAid

ProofreadingServices.com

Wordy

Grammarly

Editage

Lexico Tech Stack

Media & News

GSA Capital Partners LLP Sells 1,627,753 Shares of Lexicon Pharmaceuticals, Inc. $LXRX

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

Invus Global Management, Llc Purchases 1,538,462 Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock

Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

Lexicon Announces Proposed Public Offering of Common Stock

Financial Contrast: NovAccess Global (OTCMKTS:XSNX) vs. Lexicon Pharmaceuticals (NASDAQ:LXRX)

Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary

Lexico's Email Address Formats

Frequently Asked Questions

Where is Lexico's headquarters located?

What is Lexico's stock symbol?

What is Lexico's official website and social media links?

What is Lexico's NAICS code?

How many employees does Lexico have currently?

What industry does Lexico belong to?

What technology does Lexico use?

What is Lexico's email format?

When was Lexico founded?

Lexico

Company Overview

Media & News

GSA Capital Partners LLP Sells 1,627,753 Shares of Lexicon Pharmaceuticals, Inc. $LXRX

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

Invus Global Management, Llc Purchases 1,538,462 Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?